Advertisement
Advertisement
IKT
Inhibikase Therapeutics, Inc. Common Stock
2.06
USDSponsored
+0.07
+3.52%
May 08, 15:58 UTC -4
Closed
After-Market
2.06
0.00
+0.24%
Inhibikase Therapeutics, Inc. Common Stock Financial Snapshot
| Market Cap | 272.65M |
| Beta | 0.86 |
| Earnings Per Share (EPS) | -0.48 |
| Price-to-Book (P/B) Ratio | 0.73 |
| Operating Margin | -- |
| Total Debt/Equity (D/E) | 0.00% |
| P/E Ratio | -- |
| Return on Equity (ROE) | -46.90% |
| Current Ratio | 21.70% |
| Free Cash Flow | -27.80M |
Trending Stocks
Advertisement